Key players in the global endocrine testing market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global endocrine testing market. A few expansion strategies adopted by players operating in the global endocrine testing market are:
The report on the global endocrine testing market discussed individual strategies, followed by company profiles of manufacturers of endocrine testing products. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global endocrine testing market.
Endocrine testing market to reach US$ 10.6 Bn by 2027
Endocrine testing market is anticipated to expand at a CAGR of 6.4% from 2019 to 2027
Endocrine testing market is driven by rise in prevalence of endocrine and metabolic disorders
North America accounted for a major share of the global endocrine testing market, and the trend is anticipated to continue during the forecast period
Key players in the global endocrine testing market include Agilent Technologies, F-Hoffmann La Roche Ltd, AB SCIEX, Thermo Fisher Scientific, Abbott Laboratories
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Endocrine testing Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Endocrine testing Market Analysis and Forecasts, 2017–2027
5. Key Insights
5.1. Increasing prevalence and incidences of obesity and diabetes across globe
5.2. Technological Advancements
5.3. Key Developments
6. Global Endocrine testing Market Analysis and Forecasts, by Test Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Endocrine testing Market Value Forecast By Test Type, 2017–2027
6.3.1. Estradiol (E2) Test
6.3.2. Follicle Stimulating Hormone (FSH) Test
6.3.3. Human Chorionic Gonadotropin (hCG) Test
6.3.4. Luteinizing Hormone (LH) Test
6.3.5. Dehydroepiandrosterone sulfate (DHEAS) Test
6.3.6. Progesterone Test
6.3.7. Testosterone Test
6.3.8. Thyroid Stimulating Hormone (TSH) Test
6.3.9. Prolactin Test
6.3.10. Cortisol Test
6.3.11. Insulin Test
6.3.12. Others (Gastrin, Thymosin, Secretin, etc.)
6.4. Global Endocrine testing Market Attractiveness by Test Type
7. Global Endocrine testing Market Analysis and Forecasts, by Diagnostic Technologies
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Endocrine testing Market Value Forecast By Diagnostic Technologies, 2017–2027
7.3.1. Tandem Mass Spectrometry
7.3.2. Immunoassay technologies
7.3.3. Monoclonal and Polyclonal Antibody Technologies
7.3.4. Sensor Technologies
7.3.5. Clinical Chemistry Technologies
7.3.6. Others
7.4. Global Endocrine testing Market Attractiveness by Diagnostic Technologies
8. Global Endocrine testing Market Analysis and Forecasts, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Endocrine testing Market Value Forecast By End-user, 2017–2027
8.3.1. Hospitals
8.3.2. Commercial Laboratories
8.3.3. Ambulatory Care Centers
8.3.4. Home Based tests
8.3.5. Physician Offices
8.4. Global Endocrine testing Market Attractiveness by End-user
9. Global Endocrine testing Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Global Endocrine testing Market Value Forecast by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Endocrine testing Market Attractiveness by Region
10. North America Endocrine testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Endocrine testing Market Value Forecast by Test Type, 2017–2027
10.2.1. Estradiol (E2) Test
10.2.2. Follicle Stimulating Hormone (FSH) Test
10.2.3. Human Chorionic Gonadotropin (hCG) Test
10.2.4. Luteinizing Hormone (LH) Test
10.2.5. Dehydroepiandrosterone sulfate (DHEAS) Test
10.2.6. Progesterone Test
10.2.7. Testosterone Test
10.2.8. Thyroid Stimulating Hormone (TSH) Test
10.2.9. Prolactin Test
10.2.10. Cortisol Test
10.2.11. Insulin Test
10.2.12. Others (Gastrin, Thymosin, Secretin, etc.)
10.3. North America Endocrine testing Market Value Forecast by Diagnostic Technologies, 2017–2027
10.3.1. Tandem Mass Spectrometry
10.3.2. Immunoassay technologies
10.3.3. Monoclonal and Polyclonal Antibody Technologies
10.3.4. Sensor Technologies
10.3.5. Clinical Chemistry Technologies
10.3.6. Others
10.4. North America Endocrine testing Market Value Forecast by End-user, 2017–2027
10.4.1. Hospitals
10.4.2. Commercial Laboratories
10.4.3. Ambulatory Care Centers
10.4.4. Home Based tests
10.4.5. Physician Offices
10.5. North America Endocrine testing Market Value Forecast by Country, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Endocrine testing Market Attractiveness Analysis
10.6.1. By Test Type
10.6.2. By Diagnostic Technologies
10.6.3. By End-user
10.6.4. By Country/Sub-region
11. Europe Endocrine testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Endocrine testing Market Value Forecast by Test Type, 2017–2027
11.2.1. Estradiol (E2) Test
11.2.2. Follicle Stimulating Hormone (FSH) Test
11.2.3. Human Chorionic Gonadotropin (hCG) Test
11.2.4. Luteinizing Hormone (LH) Test
11.2.5. Dehydroepiandrosterone sulfate (DHEAS) Test
11.2.6. Progesterone Test
11.2.7. Testosterone Test
11.2.8. Thyroid Stimulating Hormone (TSH) Test
11.2.9. Prolactin Test
11.2.10. Cortisol Test
11.2.11. Insulin Test
11.2.12. Others (Gastrin, Thymosin, Secretin, etc.)
11.3. Europe Endocrine testing Market Value Forecast by Diagnostic Technologies, 2017–2027
11.3.1. Tandem Mass Spectrometry
11.3.2. Immunoassay technologies
11.3.3. Monoclonal and Polyclonal Antibody Technologies
11.3.4. Sensor Technologies
11.3.5. Clinical Chemistry Technologies
11.3.6. Others
11.4. Europe Endocrine testing Market Value Forecast by End-user, 2017–2027
11.4.1. Hospitals
11.4.2. Commercial Laboratories
11.4.3. Ambulatory Care Centers
11.4.4. Home Based tests
11.4.5. Physician Offices
11.5. Europe Endocrine testing Market Value Forecast by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. France
11.5.3. U.K.
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Endocrine testing Market Attractiveness Analysis
11.6.1. By Test Type
11.6.2. By Diagnostic Technologies
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Endocrine testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia -Pacific Endocrine testing Market Value Forecast by Test Type, 2017–2027
12.2.1. Estradiol (E2) Test
12.2.2. Follicle Stimulating Hormone (FSH) Test
12.2.3. Human Chorionic Gonadotropin (hCG) Test
12.2.4. Luteinizing Hormone (LH) Test
12.2.5. Dehydroepiandrosterone sulfate (DHEAS) Test
12.2.6. Progesterone Test
12.2.7. Testosterone Test
12.2.8. Thyroid Stimulating Hormone (TSH) Test
12.2.9. Prolactin Test
12.2.10. Cortisol Test
12.2.11. Insulin Test
12.2.12. Others (Gastrin, Thymosin, Secretin, etc.)
12.3. Asia -Pacific Endocrine testing Market Value Forecast by Diagnostic Technologies, 2017–2027
12.3.1. Tandem Mass Spectrometry
12.3.2. Immunoassay technologies
12.3.3. Monoclonal and Polyclonal Antibody Technologies
12.3.4. Sensor Technologies
12.3.5. Clinical Chemistry Technologies
12.3.6. Others
12.4. Asia -Pacific Endocrine testing Market Value Forecast by End-user, 2017–2027
12.4.1. Hospitals
12.4.2. Commercial Laboratories
12.4.3. Ambulatory Care Centers
12.4.4. Home Based tests
12.4.5. Physician Offices
12.5. Asia -Pacific Endocrine testing Market Value Forecast by Country/Sub-region, 2017–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia -Pacific Endocrine testing Market Attractiveness Analysis
12.6.1. By Test Type
12.6.2. By Diagnostic Technologies
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Endocrine testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Endocrine testing Market Value Forecast by Test Type, 2017–2027
13.2.1. Estradiol (E2) Test
13.2.2. Follicle Stimulating Hormone (FSH) Test
13.2.3. Human Chorionic Gonadotropin (hCG) Test
13.2.4. Luteinizing Hormone (LH) Test
13.2.5. Dehydroepiandrosterone sulfate (DHEAS) Test
13.2.6. Progesterone Test
13.2.7. Testosterone Test
13.2.8. Thyroid Stimulating Hormone (TSH) Test
13.2.9. Prolactin Test
13.2.10. Cortisol Test
13.2.11. Insulin Test
13.2.12. Others (Gastrin, Thymosin, Secretin, etc.)
13.3. Latin America Endocrine testing Market Value Forecast by Diagnostic Technologies, 2017–2027
13.3.1. Tandem Mass Spectrometry
13.3.2. Immunoassay technologies
13.3.3. Monoclonal and Polyclonal Antibody Technologies
13.3.4. Sensor Technologies
13.3.5. Clinical Chemistry Technologies
13.3.6. Others
13.4. Latin America Endocrine testing Market Value Forecast by End-user, 2017–2027
13.4.1. Hospitals
13.4.2. Commercial Laboratories
13.4.3. Ambulatory Care Centers
13.4.4. Home Based tests
13.4.5. Physician Offices
13.5. Latin America Endocrine testing Market Value Forecast by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Endocrine testing Market Attractiveness Analysis
13.6.1. By Test Type
13.6.2. By Diagnostic Technologies
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Endocrine testing Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Endocrine testing Market Value Forecast by Test Type, 2017–2027
14.2.1. Estradiol (E2) Test
14.2.2. Follicle Stimulating Hormone (FSH) Test
14.2.3. Human Chorionic Gonadotropin (hCG) Test
14.2.4. Luteinizing Hormone (LH) Test
14.2.5. Dehydroepiandrosterone sulfate (DHEAS) Test
14.2.6. Progesterone Test
14.2.7. Testosterone Test
14.2.8. Thyroid Stimulating Hormone (TSH) Test
14.2.9. Prolactin Test
14.2.10. Cortisol Test
14.2.11. Insulin Test
14.2.12. Others (Gastrin, Thymosin, Secretin, etc.)
14.3. Middle East & Africa Endocrine testing Market Value Forecast by Diagnostic Technologies, 2017–2027
14.3.1. Tandem Mass Spectrometry
14.3.2. Immunoassay technologies
14.3.3. Monoclonal and Polyclonal Antibody Technologies
14.3.4. Sensor Technologies
14.3.5. Clinical Chemistry Technologies
14.3.6. Others
14.4. Middle East & Africa Endocrine testing Market Value Forecast by End-user, 2017–2027
14.4.1. Hospitals
14.4.2. Commercial Laboratories
14.4.3. Ambulatory Care Centers
14.4.4. Home Based tests
14.4.5. Physician Offices
14.5. Middle East & Africa Endocrine testing Market Value Forecast by Country/Sub-region, 2017–2027
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Latin America Endocrine testing Market Attractiveness Analysis
14.6.1. By Test Type
14.6.2. By Diagnostic Technologies
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis/Ranking by Company (2018)
15.3. Company Profiles
15.3.1. Abbott Laboratories
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Financial Overview
15.3.1.3. Growth Strategies
15.3.1.4. SWOT Analysis.
15.3.2. Thermo Fisher Scientific Inc
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Financial Overview
15.3.2.3. Growth Strategies
15.3.2.4. SWOT Analysis
15.3.3. Beckman Coulter Inc
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Financial Overview
15.3.3.3. Growth Strategies
15.3.3.4. SWOT Analysis
15.3.4. Siemens Healthineers
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Financial Overview
15.3.4.3. Growth Strategies
15.3.4.4. SWOT Analysis
15.3.5. bioMerieux SA
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Financial Overview
15.3.5.3. Growth Strategies
15.3.5.4. SWOT Analysis
15.3.6. Bio-Rad Laboratories Inc
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Financial Overview
15.3.6.3. Growth Strategies
15.3.6.4. SWOT Analysis
15.3.7. Agilent Technologies Inc
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Financial Overview
15.3.7.3. Growth Strategies
15.3.7.4. SWOT Analysis
15.3.8. Sciex
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Growth Strategies
15.3.8.3. SWOT Analysis
15.3.9 F-Hoffmann La Roche AG
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Financial Overview
15.3.9.3 Growth Strategies
15.3.9.4 SWOT Analysis
List of Table
Table 01: Global Endocrine Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
Table 02: Global Endocrine Testing Market Value (US$ Mn) Forecast, by Diagnostic Technologies, 2017 2027
Table 03: Global Endocrine Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 04: Global Endocrine Testing Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 06: North America Endocrine Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 07: North America Endocrine Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
Table 08: North America Endocrine Testing Market Value (US$ Mn) Forecast, by Diagnostic Technologies, 2017–2027
Table 09: North America Endocrine Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 10: Europe Endocrine Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 11: Europe Endocrine Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
Table 12: Europe Endocrine Testing Market Value (US$ Mn) Forecast, by Diagnostic Technologies, 2017–2027
Table 13: Europe Endocrine Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 14: Asia-Pacific Endocrine Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 15: Asia-Pacific Endocrine Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
Table 08: Asia-Pacific Endocrine Testing Market Value (US$ Mn) Forecast, by Diagnostic Technologies, 2017–2027
Table 16: Asia-Pacific Endocrine Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 17: Latin America Endocrine Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 18: Latin America Endocrine Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
Table 19: Latin America Endocrine Testing Market Value (US$ Mn) Forecast, by Diagnostic Technologies, 2017–2027
Table 20: Latin America Endocrine Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027
Table 21: Middle East & Africa Endocrine Testing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 22: Middle East & Africa Endocrine Testing Market Value (US$ Mn) Forecast, by Test Type, 2017–2027
Table 23: Middle East & Africa Endocrine Testing Market Value (US$ Mn) Forecast, by Diagnostic Technologies, 2017–2027
Table 24: Middle East & Africa Endocrine Testing Market Value (US$ Mn) Forecast, by End-user, 2017–2027
List of Figure
Figure 01: Global Endocrine Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 02: Global Endocrine Testing Market Value Share, by Test Type, 2018
Figure 03: Global Endocrine Testing Market Value Share, by Diagnostic Technologies, 2018
Figure 04: Global Endocrine Testing Market Value Share, by End-user, 2018
Figure 05: Global Endocrine Testing Market Value Share, by Region, 2019–2027
Figure 06: Global Endocrine Testing Market Value Share, by Test Type, 2018-2027
Figure 07: Global Endocrine Testing Market Attractiveness Analysis, by Test Type, 2019-2027
Figure 07: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Estradiol (E2) Test
2019–2027
Figure 08: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Follicle Stimulating Hormone (FSH) Test, 2019–2027
Figure 09: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Human Chorionic Gonadotropin (hCG) Test, 2019–2027
Figure 10: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Luteinizing Hormone (LH) Test, 2019–2027
Figure 11: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Dehydroepiandrosterone sulfate (DHEAS) Test, 2019–2027
Figure 12: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Progesterone Test, 2019–2027
Figure 13: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Testosterone Test, 2019–2027
Figure 14: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Thyroid Stimulating Hormone (TSH) Test, 2019–2027
Figure 15: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Prolactin Test, 2019–2027
Figure 16: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Cortisol Test, 2019–2027
Figure 17: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Insulin Test, 2019–2027
Figure 18: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2019–2027
Figure 19: Global Endocrine Testing Market Value Share, Diagnostic Technologies, 2018-2027
Figure 20: Global Endocrine Testing Market Attractiveness Analysis, by Diagnostic Technologies, 2019- 2027
Figure 21: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Tandem Mass Spectrometry, 2019–2027
Figure 22: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Immunoassay technologies, 2019–2027
Figure 23: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Monoclonal and Polyclonal Antibody Technologies, 2019–2027
Figure 24: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Sensor Technologies, 2019–2027
Figure 25: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Clinical Chemistry Technologies, 2019–2027
Figure 25: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2019–2027
Figure 26: Global Endocrine Testing Market Value Share, End-user, 2018-2027
Figure 27: Global Endocrine Testing Market Attractiveness Analysis, by End-user, 2019- 2027
Figure 28: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2019–2027
Figure 29: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Commercial Laboratories, 2019–2027
Figure 30: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Ambulatory Care Centers, 2019–2027
Figure 31: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Home Based tests, 2019–2027
Figure 32: Global Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), by Physician Offices, 2019–2027
Figure 33: Global Endocrine Testing Market Value Share, by Region, 2018 and 2027
Figure 34: Global Endocrine Testing Market Attractiveness, by Region, 2019–2027
Figure 35: North America Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2027
Figure 36: North America Endocrine Testing Market Value Share Analysis, by Country, 2018 and 2027
Figure 37: North America Endocrine Testing Market Attractiveness Analysis, by Country, 2019 – 2027
Figure 38: North America Endocrine Testing Market Value Share Analysis, by Test Type, 2018 and 2027
Figure 39: North America Endocrine Testing Market Attractiveness Analysis, by Test Type, 2019 – 2027
Figure 40: North America Endocrine Testing Market Value Share Analysis, by Diagnostic Technologies, 2018 and 2027
Figure 41: North America Endocrine Testing Market Attractiveness Analysis, by Diagnostic Technologies, 2019 – 2027
Figure 42: North America Endocrine Testing Market Value Share Analysis, by End-user, 2018 and 2027
Figure 43: North America Endocrine Testing Market Attractiveness Analysis, by End-user, 2019 – 2027
Figure 44: Europe Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2027
Figure 45: Europe Endocrine Testing Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 46: Europe Endocrine Testing Market Attractiveness Analysis, by Country/Sub-region, 2019 – 2027
Figure 47: Europe America Endocrine Testing Market Value Share Analysis, by Test Type, 2018 and 2027
Figure 48: Europe Endocrine Testing Market Attractiveness Analysis, by Test Type, 2019 – 2027
Figure 49: Europe Endocrine Testing Market Value Share Analysis, by Diagnostic Technologies, 2018 and 2027
Figure 50: Europe Endocrine Testing Market Attractiveness Analysis, by Diagnostic Technologies, 2019 – 2027
Figure 51: Europe Endocrine Testing Market Value Share Analysis, by End-user, 2018 and 2027
Figure 52: Europe Endocrine Testing Market Attractiveness Analysis, by End-user, 2019 – 2027
Figure 53: Asia-Pacific Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2027
Figure 54: Asia-Pacific Endocrine Testing Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 55: Asia-Pacific Endocrine Testing Market Attractiveness Analysis, by Country/Sub-region, 2019 – 2027
Figure 56: Asia-Pacific America Endocrine Testing Market Value Share Analysis, by Test Type, 2018 and 2027
Figure 57: Asia-Pacific Endocrine Testing Market Attractiveness Analysis, by Test Type, 2019 – 2027
Figure 58: Asia-Pacific Endocrine Testing Market Value Share Analysis, by Diagnostic Technologies, 2018 and 2027
Figure 59: Asia-Pacific Endocrine Testing Market Attractiveness Analysis, by Diagnostic Technologies, 2019 – 2027
Figure 60: Asia-Pacific Endocrine Testing Market Value Share Analysis, by End-user, 2018 and 2027
Figure 61: Asia-Pacific Endocrine Testing Market Attractiveness Analysis, by End-user, 2019 – 2027
Figure 62: Latin America Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2027
Figure 63: Latin America Endocrine Testing Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 64: Latin America Endocrine Testing Market Attractiveness Analysis, by Country/Sub-region, 2019 – 2027
Figure 65: Latin America Endocrine Testing Market Value Share Analysis, by Test Type, 2018 and 2027
Figure 66: Latin America Endocrine Testing Market Attractiveness Analysis, by Test Type, 2019 – 2027
Figure 67: Latin America Endocrine Testing Market Value Share Analysis, by Diagnostic Technologies, 2018 and 2027
Figure 68: Latin America Endocrine Testing Market Attractiveness Analysis, by Diagnostic Technologies, 2019 – 2027
Figure 69: Latin America Endocrine Testing Market Value Share Analysis, by End-user, 2018 and 2027
Figure 70: Latin America Endocrine Testing Market Attractiveness Analysis, by End-user, 2019 – 2027
Figure 71: Middle East & Africa Endocrine Testing Market Value (US$ Mn) and Y-o-Y Growth (%), 2017–2027
Figure 72: Middle East & Africa Endocrine Testing Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 73: Middle East & Africa Endocrine Testing Market Attractiveness Analysis, by Country/Sub-region, 2019 – 2027
Figure 74: Middle East & Africa Endocrine Testing Market Value Share Analysis, by Test Type, 2018 and 2027
Figure 75: Middle East & Africa Endocrine Testing Market Attractiveness Analysis, by Test Type, 2019 – 2027
Figure 76: Middle East & Africa Endocrine Testing Market Value Share Analysis, by Diagnostic Technologies, 2018 and 2027
Figure 77: Middle East & Africa Endocrine Testing Market Attractiveness Analysis, by Diagnostic Technologies, 2019 – 2027
Figure 78: Middle East & Africa Endocrine Testing Market Value Share Analysis, by End-user, 2018 and 2027
Figure 79: Middle East & Africa Endocrine Testing Market Attractiveness Analysis, by End-user, 2019 – 2027
Figure 80: Global Endocrine Testing Market Share, by Company, 2018
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Endocrine Testing Market
